FOXP1 is an androgen-responsive transcription factor that negatively regulates androgen receptor signaling in prostate cancer cells
about
The distinct and overlapping phenotypic spectra of FOXP1 and FOXP2 in cognitive disordersFoxp1 Regulates the Proliferation of Hair Follicle Stem Cells in Response to Oxidative Stress during Hair CyclingAndrogen modulation of Foxp1 and Foxp2 in the developing rat brain: impact on sex specific vocalizationScreening of whole genome sequences identified high-impact variants for stallion fertility.Integrative analysis of FOXP1 function reveals a tumor-suppressive effect in prostate cancerTACC2 is an androgen-responsive cell cycle regulator promoting androgen-mediated and castration-resistant growth of prostate cancerGene expression profile analysis identifies metastasis and chemoresistance-associated genes in epithelial ovarian carcinoma cells.CAMK2N1 inhibits prostate cancer progression through androgen receptor-dependent signaling.FOXP1 functions as an oncogene in promoting cancer stem cell-like characteristics in ovarian cancer cellsFOXP1 forkhead transcription factor is associated with the pathogenesis of endometrial cancerPrognostic value of decreased FOXP1 protein expression in various tumors: a systematic review and meta-analysisEpstein-Barr virus encoded miR-BART11 promotes inflammation-induced carcinogenesis by targeting FOXP1.Transcriptional network of androgen receptor in prostate cancer progression.FOXP1 enhances tumor cell migration by repression of NFAT1 transcriptional activity in MDA-MB-231 cells.Recurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct subgroup of aggressive ERG fusion-positive prostate cancers.Crosstalk of the Androgen Receptor with Transcriptional Collaborators: Potential Therapeutic Targets for Castration-Resistant Prostate CancerARFGAP3, an androgen target gene, promotes prostate cancer cell proliferation and migration.Expression of FOXP1 in epithelial ovarian cancer (EOC) and its correlation with chemotherapy resistance and prognosis.Novel Biomarker Signature That May Predict Aggressive Disease in African American Men With Prostate Cancer.Estrogen and Androgen Blockade for Advanced Prostate Cancer in the Era of Precision Medicine.FOXP1, an estrogen-inducible transcription factor, modulates cell proliferation in breast cancer cells and 5-year recurrence-free survival of patients with tamoxifen-treated breast cancer.Association of double-positive FOXA1 and FOXP1 immunoreactivities with favorable prognosis of tamoxifen-treated breast cancer patients.Downregulation of FOXP2 promoter human hepatocellular carcinoma cell invasion.The untold stories of the speech gene, the FOXP2 cancer gene.
P2860
Q24629522-7BCEE4EF-4521-48BE-BDBA-2168F61EC970Q27303469-2A3AC039-F420-4512-90F2-16D0D33D9F1EQ28564993-32ADACC2-92CD-41D1-A5D1-1344CE4AD19FQ30386897-F31D8173-B768-4A9D-B142-7AC6C9D082BBQ33631876-2C7A6AF2-A882-41C2-AAD8-B3BD68E8EE7AQ33636574-5B0BBAFC-F42A-44A9-BBDE-F5B937635936Q34675214-89CC3742-516A-48AA-A17D-5D3C280D7E1BQ34786431-C748DE03-2899-4435-9F85-8BE2EFAD3736Q36772183-253C8D82-76C1-481B-AC40-13DAE2F9BD03Q37097153-71DABB44-9A8C-46CB-ABE1-5558446BF756Q37125561-50DAB222-7B03-41FB-9049-7EAC5602C18AQ37392833-7C4E2D7D-7C52-48C3-A061-03ACA752DAC4Q38100269-F9A153B8-4B80-49C2-8755-7614B938B795Q38730495-01A7E845-670E-4C41-A548-156DB650E2D1Q39136055-31AFE6B2-0853-46FF-9284-C4BD4840A049Q39164084-E1DB21A2-DF95-4EA9-839E-7E72A6D9FFA2Q39529369-D2401E46-F676-4343-A1E9-10F3B5C5D1CCQ41037797-8362D345-906C-43B5-B4BD-F99DF5D0DE0EQ41564129-6EBA98BF-A359-403D-BAED-6965CCAABF62Q47717137-A66CCDA6-791F-4B26-8FE1-BB3F814D2E21Q51546067-9AE0D42A-65EA-4A18-8039-42519A877B7AQ53175662-9985A6D4-B9F9-4CC2-B3BE-FE76D58F7618Q53440458-4F158DF4-87A1-45B0-9E14-581995A61097Q55364192-5F41547A-50B9-4BF4-AC82-EF09DB6C6EE7
P2860
FOXP1 is an androgen-responsive transcription factor that negatively regulates androgen receptor signaling in prostate cancer cells
description
2008 nî lūn-bûn
@nan
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
FOXP1 is an androgen-responsiv ...... aling in prostate cancer cells
@ast
FOXP1 is an androgen-responsiv ...... aling in prostate cancer cells
@en
FOXP1 is an androgen-responsiv ...... aling in prostate cancer cells
@en-gb
FOXP1 is an androgen-responsiv ...... aling in prostate cancer cells
@nl
type
label
FOXP1 is an androgen-responsiv ...... aling in prostate cancer cells
@ast
FOXP1 is an androgen-responsiv ...... aling in prostate cancer cells
@en
FOXP1 is an androgen-responsiv ...... aling in prostate cancer cells
@en-gb
FOXP1 is an androgen-responsiv ...... aling in prostate cancer cells
@nl
prefLabel
FOXP1 is an androgen-responsiv ...... aling in prostate cancer cells
@ast
FOXP1 is an androgen-responsiv ...... aling in prostate cancer cells
@en
FOXP1 is an androgen-responsiv ...... aling in prostate cancer cells
@en-gb
FOXP1 is an androgen-responsiv ...... aling in prostate cancer cells
@nl
P2093
P3181
P1476
FOXP1 is an androgen-responsiv ...... aling in prostate cancer cells
@en
P2093
Kayoko Murakami
Kazuhiro Ikeda
Kenichi Takayama
Kuniko Horie-Inoue
Satoshi Inoue
Tomohiko Urano
Yasuyoshi Ouchi
P304
P3181
P356
10.1016/J.BBRC.2008.07.056
P407
P577
2008-09-19T00:00:00Z